FDA Inspection 1267899 — Aino Co., Ltd. Of North China Pharma. Group
The FDA completed an inspection of Aino Co., Ltd. Of North China Pharma. Group on Mar 14, 2025 in Shijiazhuang, Hebei. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 14, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Shijiazhuang, Hebei (China)